Cleo Diagnostics Ltd (COV) — Financial Flexibility Index
Cleo Diagnostics Ltd (COV) has a Financial Flexibility Index of -1.47x as of December 2025. Free cash flow of AU$-1.67 Million (operating CF AU$-1.67 Million minus capex AU$1.96K) represents -1% of total liabilities (AU$1.14 Million). Also explore Cleo Diagnostics Ltd (COV) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cleo Diagnostics Ltd Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Cleo Diagnostics Ltd across 3 annual periods. Check COV strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cleo Diagnostics Ltd (2023–2025)
Year-by-year free cash flow to debt coverage for Cleo Diagnostics Ltd. For the full company profile including market capitalisation, see how much is Cleo Diagnostics Ltd worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.62x | AU$-2.89 Million | AU$-2.90 Million | AU$1.10 Million | ▲ +37.1% |
| 2024 | -4.17x | AU$-2.03 Million | AU$-2.03 Million | AU$486.22K | ▼ -2346.6% |
| 2023 | -0.17x | AU$-344.23K | AU$-684.47K | AU$2.02 Million | — |